各种介入治疗肝癌方法临床评价

doi:10.3969/j.issn.1672-5069.2015.02.003

Abstract

Yang Jinhui, Tang Yingmei. Evaluation of interventional therapy for patients with hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 230-232.

[1] Lencioni R,Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology,2012,262（1）:43-58.
[2] Lewandowski RJ,Geschwind JF,Liapi E,et al. Transcatheter intraarterial therapies:rationale and overview. Radiology,2011,259（3）:641-657.
[3] Georgiades C,Geschwind JF,Harrison N,et al. Lack of response after initial chemoembolization for hepatocellular carcinoma:does it predict failure of subsequent treatment. Radiology,2012,265（1）:115-123.
[4] Luo J,Guo RP,Lai EC,et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis:a prospective comparative study. Ann Surg Oncol,2011,18（2）:413-420.
[5] 王建华. 肝癌综合介入治疗的进展. 中华介入放射学电子杂志,2013,1（1）:61-64.
[6] Prajapati HJ,Xing M,Spivey JR,et al. Survival,efficacy,and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC. AJR,2014,203（6）:W706-W714.
[7] Yu SC,Hui JW,Hui EP,et al. Unresectable hepatocellular carcinoma:randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization.Radiology,2014,270（2）:607-620.
[8] 黄兢姚,杨维竹,江娜,等. 经皮门静脉栓塞治疗肝癌的临床应用. 介入放射学杂志,2006,15（11）:664-666.
[9] 曹玮,万教,张洪新,等. 肝动脉、门静脉双介入治疗对肝癌患者微循环状态的影响. 现代肿瘤医学,2008,16（11）:1958-1959.
[10] Lee DH,Lee JM,Lee JY,et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment:long-term results and prognostic factors in 162 patients with cirrhosis. Radiology,2014,270（3）:900-909.
[11] Huang G,Chen X,Lau WY,et al. Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas.Br J Surg,2014,101（8）:1006-1015.
[12] Kariyama K,Nouso K,Wakuta A,et al. Percutaneous radiofrequency ablation for treatment of hepatocellular carcinoma in the caudate lobe. AJR,2011,197（4）:W571-W575.
[13] Xu HX,Wang Y,Lu MD,et al. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol, 2012,85（1016）:1078-1084.
[14] Pereira PL,Trübenbach J,Schenk M,et al. Radiofrequency ablation:in vivo comparison of four commercially available devices in pig livers. Radiology,2004,232（2）:482-490.
[15] Curley SA,Izzo F,Ellis LM,et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg,2000,232:381-391.
[16] Wood TF,Rose DM,Chung M,et al. Radiofrequency ablation of 231 unresectable hepatic tumors:indications,limitations and complications. Ann Surg Oncol,2000,7（8）:593-600.
[17] 彭晓君,王春平,任永强,等. 经皮射频毁损治疗96例肝癌疗效分析. 中国现代医学杂志,2003,13（4）:39-42.
[18] Takaki H,Yamakado K,Nakatsuka A,et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions:single-center experience. AJR,2013,200（3）:658-664.
[19] Ishizaka H,Awata S,Arai H,et al. CT-guided radiofrequency liver tumour ablation:use of a two-step coaxial system with a fine guide needle wire unit for high-risk cases. Br J Radiol,2010,83（996）:1077-1079.
[20] Goldberg SN. Science to practice:why debate the role of Dbait for improving tumor ablation. Radiology,2014,270（3）:635-637.
[21] Mahnken AH,Pereira PL,de Baère T. Interventional oncologic approaches to liver metastases. Radiology,2013,266（2）:407-430.
[22] 赵新建,岳丽娟.肝癌介入治疗的研究现状. 农垦医学,2006,28（5）:380-384.

Evaluation of interventional therapy for patients with hepatocellular carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[3]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[4]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[5]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[6]	Qiao Zhizhong. Value of contrast-enhanced ultrasonography in differential diagnosis of patients with focal nodular hyperplasia and hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 421-424.
[7]	Zhu Guangxi，Wen Liangzhi，Chen Dongfeng. Pathogenesis of non-alcoholic fatty liver disease-related hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 453-456.
[8]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[9]	Xing Diankui, Cheng Jing. Clinical value of ¹⁸F-FDG PET/CT scan in patients with hepatocellular carcinoma and hepatic microvascular invasion [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 252-254.
[10]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Wang Zhaoxia, Guan Ke, Fu Sanxian, Wang Huijie. Early administration of enteral nutrition in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 272-275.
[13]	Zhao Xitai, Nie Qinghe. Serum microRNA in diagnosis of patients with hepatocellular carcinoma and methodological progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 297-300.
[14]	Fan Jiangao.. Highlights of Journal of Practical Hepatology in 2018 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 1-3.
[15]	Chen Yongqi, Chen Qian, Yuan Chunyan, et al.. Cancerous and noncancerous expression of Ep-CAM and C-Kit in patients with hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 109-112.